BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22132402)

  • 1. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.
    Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG
    Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads.
    Moschouris H; Malagari K; Kornezos I; Papadaki MG; Gkoutzios P; Matsaidonis D
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1215-22. PubMed ID: 20556386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis.
    Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.
    Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M
    Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of intrahepatic progression of hepatocellular carcinoma post transarterial chemoembolization. A long-term, prospective evaluation of contrast-enhanced ultrasonography (CEUS).
    Moschouris H; Kalokairinou-Motogna M; Vrakas S; Papadatou A; Karagiannis E; Kiltenis M; Kladis-Kalentzis K; Marmaridou K; Papadogeorgopoulos N; Malagari K
    Med Ultrason; 2017 Apr; 19(2):134-142. PubMed ID: 28440346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S; Schulze M; Spira D; Horger M
    Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sono-hepatic-arteriography (Sono-HA) in the assessment of hepatocellular carcinoma in patients undergoing transcatheter arterial chemoembolization (TACE).
    Schacherer D; Girlich C; Zorger N; Wiest R; Schoelmerich J; Feuerbach S; Jung EM
    Ultraschall Med; 2010 Jun; 31(3):270-5. PubMed ID: 20408118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of three-dimensional angiography with a flat panel detector of direct conversion type in a transcatheter arterial chemoembolization procedure for hepatocellular carcinoma: initial experience.
    Kakeda S; Korogi Y; Hatakeyama Y; Ohnari N; Oda N; Nishino K; Miyamoto W
    Cardiovasc Intervent Radiol; 2008; 31(2):281-8. PubMed ID: 18026792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
    Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol.
    Bo J; Peng H; LianHua Z; Xiang F; YuKun L
    BMC Cancer; 2021 Nov; 21(1):1171. PubMed ID: 34727882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
    Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term evaluation of liver tumors after transarterial chemoembolization: limitations and feasibility of contrast-enhanced ultrasonography.
    Moschouris H; Malagari K; Papadaki MG; Kornezos I; Gkoutzios P; Tepelenis N; Matsaidonis D
    Abdom Imaging; 2011 Dec; 36(6):718-28. PubMed ID: 21253722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
    Bartolotta TV; Taibbi A; Matranga D; Midiri M; Lagalla R
    Radiol Med; 2015 Aug; 120(8):695-704. PubMed ID: 25698299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
    Iwazawa J; Ohue S; Mitani T; Abe H; Hashimoto N; Hamuro M; Nakamura K
    AJR Am J Roentgenol; 2009 Apr; 192(4):1057-63. PubMed ID: 19304714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
    Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
    Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
    Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.